|
|
|
|
Synta and Roche Ink Billion-Dollar Inflammatory Disease Deal
GEN News Highlights GEN News Highlights Rocheand Synta Pharmaceuticals entered an agreement potentially worth $1.025 billion to discover, develop, and commercialize small molecule anti-inflammatories.Roche will pay Synta $25 million...
|
|
|
Medical management of patients with ileal pouch anal anastomosis after restorative procto-colectomy
--- COLORECTAL CANCER/POLYPS TOP ARTICLES --- Journal of Clinical Oncology, 12/31/08 Archives of Internal Medicine, 11/25/08 The Lancet Oncology - Online First, 11/12/08 --- GI ONCOLOGY TOP ARTICLES --- Journal of Clinical Oncology, 12/31/08...
|
|
|
TopAbstracts in Viral Infections 01/05/2009
TopAbstracts in Viral Infections are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.Over 2000 peer...
|
|
|
Studies Examine Inflammatory Biomarker in Prevention and Prediction of Heart Disease
_ Studies Examine Inflammatory Biomarker in Prevention and Prediction of Heart Disease.
Journal of the American Medical Association:
Jan 6 2009 9:39PM
Matching: inflammatory disease
|
Find similar documents
|
|
|
|
Inflammatory Factors And Diabetic Macular Edema Highlighted In Ophthalmology Jan. 2009
Eye Health / Blindness News Main Category: Eye Health / Blindness Also Included In: Diabetes; Immune System / Vaccines email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health...
|
|
|
Inflammatory Factors May be Key to Controlling Diabetic Macular Edema
Research Highlighted in the January 2009 Issue of Ophthalmology SAN FRANCISCO--(BUSINESS WIRE)--Jan 5, 2009 - With a new study from the Centers for Disease Control and Prevention predicting that diabetic retinopathy will triple from 5...
|
|
|
Inflammatory Factors May be Key to Controlling Diabetic Macular Edema
With a new study from the Centers for Disease Control and Prevention predicting that diabetic retinopathy will triple from 5.5 million in 2005 to 16 million in 2050, improved treatments are urgently needed for this leading cause of...
|
|
|
Joint Destruction Biomarkers For Anti-il-17a Therapy Of Inflammatory Joint Disease
SCHERING CORPORATION BOWMAN, Edward, Paul CHAO, Cheng-chi CHEN, Shi-Juan BOWMAN, Edward, Paul CHAO, Cheng-chi CHEN, Shi-JuanTitle Abstract Novel methods and drug products for treating inflammatory joint diseases such as rheumatoid arthriti...
|
|
|
Healthcare Costs Prevented Nearly 40 Million Americans From Filling Their Prescriptions in 2008
/PRNewswire/ -- Nearly 40 million U.S.adults decided not to fill a prescription medication from a doctor in the past year because of the cost, according to pharmaceutical and healthcare market research company Manhattan Research's...
|
|
|
To Manage Costs of Hemophilia, Patients Need More Than Clotting Factor
Table of Contents Feed for the Digital Edition of Biotechnology Healthcare - November/December 2008 Biotechnology Healthcare - November/December 2008 Openers Contents Editorial/David B.Nash, MD, MBA Personalized Medicine Inflammatory...
|
|
|
Copayment Foundations: Help for the Underinsured
Table of Contents Feed for the Digital Edition of Biotechnology Healthcare - November/December 2008 Biotechnology Healthcare - November/December 2008 Openers Contents Editorial/David B.Nash, MD, MBA Personalized Medicine Inflammatory...
|
|
|
Acute Cytomegalovirus Infection Is a Risk Factor in Refractory and Complicated Inflammatory Bowel Disease
Maher MM et al.- High clinical index of suspicion for the association of CMV infection with IBD should be directed towards female IBD patients presenting with fever, lymphadenopathy, splenomegaly, leucopenia, and mild hepatitis. Acute...
|
|
|
Healthcare Costs Prevented Nearly 40 Million Americans From Filling Their Prescriptions In 2008
Nearly 40 million U.S.adults decided not to fill a prescription medication from a doctor in the past year because of the cost, according to pharmaceutical and healthcare market research company Manhattan Research's Cybercitizen Health v8...
|
|
|
Mice Without IL-22 Have More Severe Inflammatory Bowel Disease
_ Mice Without IL-22 Have More Severe Inflammatory Bowel Disease.
|
|
|
Glaxo, Dynavax To Develop Immuno-Inflammatory Disease Treatments
NEW YORK -(Dow Jones)- GlaxoSmithKline (GSK) signed a partnership to develop treatments for immuno-inflammatory diseases with Dynavax Technologies Corp.( DVAX), which could eventually reap worth more than $800 million including all...
National AIDS Treatment Advocacy Project:
Dec 19 2008 6:56PM
Matching: inflammatory disease
|
Find similar documents
|
|
|
|
Mice Without IL-22 Have More Severe Inflammatory Bowel Disease
_ Mice Without IL-22 Have More Severe Inflammatory Bowel Disease.
Abstracts in Hematology and Oncology:
Dec 19 2008 6:01PM
Matching: inflammatory disease
|
Find similar documents
|
|
|
|
Gut Instincts: What Harms Some Cells May Protect Against Inflammatory Bowel Disease
In a finding that could lead to improved treatment of chronic inflammatory bowel disease (IBD), Yale University researchers have uncovered a key mechanism in the immune system that appears to offer protection from the disorder.Their work...
|
|
|
Musculoskeletal system: Why is this 18-month-old dog limping? (Proceedings)
Source: CVC CENTRAL Email|Print| Del.icio.us Digg Reddit Facebook |Save|License General Comments Disease processes are categorized into Congenital, Degenerative, Developmental Inflammatory, Metabolic, Neoplastic, Traumatic and...
Thomson Veterinary Healthcare Communications:
Dec 17 2008 5:39AM
Matching: pelvic inflammatory disease
|
Find similar documents
|
|
|
|
Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and
1 Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, California, USA 2 Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA 3 Division of Gastroenterology and Hepatology,...
|
|
|
Glaxo, Dynavax To Develop Immuno-Inflammatory Disease Treatments
NEW YORK In return, Glaxo will get an exclusive option over four programs targeting diseases such as lupus, psoriasis, and rheumatoid arthritis.Dynavax shares, which closed Tuesday at 26 cents The stock plummeted another 80% in late...
|
|
|
Glaxo, Dynavax To Develop Immuno-Inflammatory Disease Treatments
NEW YORK -(Dow Jones)- GlaxoSmithKline (GSK) signed a partnership to develop treatments for immuno-inflammatory diseases with Dynavax Technologies Corp.( DVAX), which could eventually reap worth more than $800 million including all...
|
|
|
Methods of using IL-1 antagonists to treat autoinflammatory disease
Title: United States Patent: 7,459,426 Inventors: Mellis; Scott (New Rochelle, NY), Karow; Margaret (Putnam Valley, NY), Yancopoulos; George D.(Yorktown Heights, NY), Papadopoulos; Joanne (LaGrangeville, NY) Assignee: Regeneron...
|
|
|
Inflammatory bowel disease (Proceedings)
Inflammatory bowel disease (IBD) in dogs and cats is the name used for many disorders of the small and large bowel of the gastrointestinal tract.IBD is a term that is an umbrella that covers many mechanisms of disease, many of which...
Thomson Veterinary Healthcare Communications:
Dec 14 2008 8:51PM
Matching: inflammatory disease
|
Find similar documents
|
|
|
|
Michael Karin, Professor At UCSD To Give Keynote Speech At 7th Cytokines And Inflammation Conference
Michael Karin, Professor of Pharmacology Tumor Growth Invasion and Metastasis at UCSD to Give Keynote Speech at GTCbio's 7th Cytokines and Inflammation Conference on January 29-30, 2009 in San Diego, CA Dr.Michael Karin, Professor of...
|
|
|
Pluristem Receives $1.6M Grant from the Office of IsraelEURs Chief Scientist
- Pluristem Therapeutics Inc.(NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic), off-the-shelf, cell therapy products for a variety of degenerative, ischemic and...
|
